Calamos Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
Calamos Advisors's TDAC Position: Q3 2026 in Review
Calamos Advisors held its Translational Development Acquisition Corp (TDAC) position steady in Q3 2026 at 371,532 shares worth $4.03M. The position accounts for 0.01% of the portfolio, ranked #583.
Calamos Advisors first reported a position in TDAC in Q2 2026 and has held it in 2 quarters since. 18 funds tracked by Wall St. Rank hold TDAC as of Q3 2026.
- Calamos Advisors held 371,532 shares of Translational Development Acquisition Corp worth $4.03M as of Q3 2026.
- Calamos Advisors left its Translational Development Acquisition Corp share count unchanged in Q3 2026.
- Translational Development Acquisition Corp made up 0.01% of Calamos Advisors's portfolio in Q3 2026, its #583 holding.
- Calamos Advisors first reported a position in Translational Development Acquisition Corp in Q2 2026 and has held it in 2 quarters since.
- 18 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q3 2026.
Based on Calamos Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.